Accordingly, here we utilized several TCGA datasets to define the gene expression signature of malignancies that express reduced levels of the newly discovered tumor suppressor Tristetraprolin (TTP, ZFP36) [2]. This evidence concerns the gene ZFP36 and neoplasm.